The Scientist

» drug development

Most Recent

Biotechs have developed enzyme replacements and genetically modified probiotics to treat patients with the rare metabolic disorder.

0 Comments

image: Immunotherapy More Effective in Men: Study

Immunotherapy More Effective in Men: Study

By Kerry Grens | May 18, 2018

Women with metastatic cancer who were treated with a checkpoint inhibitor had a smaller benefit than did men.

0 Comments

image: FDA Approves Drug to Ease Symptoms of Opioid Withdrawal

FDA Approves Drug to Ease Symptoms of Opioid Withdrawal

By Catherine Offord | May 17, 2018

Lucemyra is the first non-opioid drug to be approved in the U.S. specifically for this purpose.

0 Comments

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull together real-world results.  

0 Comments

image: Researchers Develop a Drug Against the Common Cold

Researchers Develop a Drug Against the Common Cold

By Catherine Offord | May 15, 2018

In an in vitro study, the compound completely blocked the replication of rhinoviruses.

2 Comments

image: Research Scandal Involving Popular Heart Drug Engulfs Three More Papers

Research Scandal Involving Popular Heart Drug Engulfs Three More Papers

By Alison McCook, Retraction Watch | May 4, 2018

The scientists involved have hired lawyers to fight the conclusions of a recent investigation into some studies of Diovan in Japan.

3 Comments

image: Ten-Minute Sabbatical

Ten-Minute Sabbatical

By The Scientist Staff | May 1, 2018

Take a break from the bench to puzzle and peruse.

0 Comments

Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

1 Comment

image: Bioengineers Use Yeast to Manufacture Drugs

Bioengineers Use Yeast to Manufacture Drugs

By Jim Daley | April 3, 2018

The yeast’s output of noscapine, a cough suppressant naturally made by poppies, is 18,000-fold higher than previous attempts.

0 Comments

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. “Public” T-Cell Receptors From Resistant People Fend Off HIV